SEC Form 4 · accession 0001209191-17-032818
BIOTELEMETRY, INC. · BEAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J. Rubin
Director
Period of report
May 12, 2017
Accepted (ET)
May 16, 2017 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001574774
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 12, 2017 | A | 4,619 | $0.00 | A | 149,047 | D | |
| Common Stock | May 15, 2017 | M | 15,000 | $7.20 | A | 164,047 | D | |
| Common StockF3 | May 15, 2017 | S | 15,000 | $28.14 | D | 149,047 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $7.20 | May 15, 2017 | M | 15,000 | D | Sep 24, 2007 | Sep 24, 2017 | Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1Represents shares of the Issuer's common stock underlying restricted stock units (RSUs) awarded to the Reporting Person. The RSUs shall vest annually following the award date. In the event of the occurrence of the Reporting Person's death, Disability (within the meaning of such term under section 409A(a)(2)(C) of the Internal Revenue Code of 1986, as amended (the "Code")), "separation from service" (within the meaning of such term under Code section 409A(a)(2)(A)(i)) or a 409A Change in Control Event (as defined in the award agreement) prior to the full vesting date, all outstanding RSUs shall be fully vested. The shares of common stock underlying the RSUs will be issued when the RSUs vest.
- F2Includes 4,619 shares of the Issuer's common stock subject to the reported RSU award.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.95 to $28.30, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.